Efficacy and safety of first-line modified docetaxel, cisplatin, and fluorouracil (mDCF) in advanced esophageal cancer: A retrospective study from Viet Nam.
| Published in: | Journal of Clinical Oncology Vol. 44; pp. 97 - 163 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2026 Supplement 19
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194781541&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194781541 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2026 Supplement 19 vid: 44 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 194781541 10.1200/JCO.2026.44.19_suppl.97 194781541 ppf: 97 ppct: 66 formats: tig: atl: Efficacy and safety of first-line modified docetaxel, cisplatin, and fluorouracil (mDCF) in advanced esophageal cancer: A retrospective study from Viet Nam. aug: au: Can, Hong Thi Anh Nguyen Thi Huong, Giang Tran, Dung Xuan Hoang, Giap Ngoc affil: Vietnam National Cancer Hospital, Hanoi, Viet Nam sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|